AVXL
1.26 USD
-0.80%
Today
+3.33%
1D
Market is open
Sun
Closed
Mon
4:30 PM ~ 10:59 PM
Tue
4:30 PM ~ 10:59 PM
Wed
4:30 PM ~ 10:59 PM
Thu
4:30 PM ~ 10:59 PM
Fri
4:30 PM ~ 10:59 PM
Sat
Closed
Information
Name
Anavex Life Sciences
Currency
USD
Market Cap
111.24M
Avg Daily Volume
1.03M
52 Week High
7.791 USD
52 Week Low
1.13 USD
Trading Hours
See hours
Business Summary
Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and various types of cancer. Its lead drug candidate, ANAVEX 2-73 (blarcamesine), which has completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease; a Phase 2 proof-of-concept study in Parkinson's disease dementia; and a Phase 2 and a Phase 3 study in adult patients and one Phase 2/3 study in pediatric patients with Rett syndrome. Its ANAVEX 2-73 is an orally available drug designed to restore cellular homeostasis by targeting SIGMAR1 and muscarinic receptors, as well as exhibits anticonvulsant, anti-amnesic, neuroprotective, and anti-depressant properties in animal models indicating its potential to treat additional CNS disorders, including epilepsy. The company's ANAVEX 3-71 that targets SIGMAR1 and M1 muscarinic receptors, which is a clinical stage drug candidate demonstrating disease-modifying activity against Alzheimer's disease in transgenic (3xTg-AD) mice, such as cognitive deficits, amyloid, and tau pathologies. Anavex Life Sciences Corp. was incorporated in 2004 and is headquartered in New York, New York.
Top News
Anavex
+6.03%
Anavex Life Sciences appoints Terrie Kellmeyer as CEO
tradingview.com
1d ago
Anavex
+6.03%
Anavex board chair Jiong Ma and director Gautam Patel resign
tradingview.com
1d ago
Anavex
+6.03%
IWB_CFD
+1.85%
UMB_Financial
+2.62%
Glaukos
+7.44%
Ocugen
+19.18%
Veritone
+7.69%
Accendra.Health
+17.39%
AREC
-1.72%
Eyepoint.Pharmaceuticals
+5.71%
Heron
+3.85%
Invivyd
+12.96%
Karyopharm
+0.00%
Optimum.Communication
+18.97%
Oscar.Health
+9.43%
PLBY_Group
+5.43%
Wheelsup
+0.32%
Voyager.Therapeutics
+7.56%
Russell 2000 estimated to drop 83 stocks in December rebalance - Stephens
tradingview.com
5d ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
